Cargando…

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α

Efficacy of beraprost sodium (BPS) combined with alprostadil on diabetic nephropathy (DN) and its influence on renin angiotensin system (RAS) and TNF-α were investigated. One hundred and two patients with type 2 diabetic nephropathy admitted to Weifang People's Hospital from July 2017 to Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xinwei, Pan, Xiaojing, Li, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913236/ https://www.ncbi.nlm.nih.gov/pubmed/31885702 http://dx.doi.org/10.3892/etm.2019.8265

Ejemplares similares

THE EFFECT OF RENNIN UPON CASEIN : I. THE SOLUBILITY OF PARACASEIN IN SODIUM HYDROXIDE.
por: Pertzoff, Vladimir
Publicado: (1927)

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
por: Na, Ki Young, et al.
Publicado: (2013)

Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy
por: Hong, Yan, et al.
Publicado: (2017)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Author Correction: Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2019)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension
por: Takami, Takeshi, et al.
Publicado: (2012)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Study the influence of culture conditions on rennin production by Rhizomucor miehei using solid-state fermentations
por: Aljammas, Houthail Alahmad, et al.
Publicado: (2018)

THE EFFECT OF RENNIN UPON CASEIN : II. FURTHER CONSIDERATION OF THE PROPERTIES OF PARACASEIN.
por: Pertzoff, Vladimir
Publicado: (1928)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials
por: Fu, Hongfang, et al.
Publicado: (2022)

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
por: Jung, Seung Mook
Publicado: (2019)

Plasma rennin activity: Early indicator of renal injury in bilateral pelviureteric junction obstruction in children
por: Singh, Amit, et al.
Publicado: (2014)

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
por: Sato, Nahoko, et al.
Publicado: (2010)

A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease
por: Takenaka, M., et al.
Publicado: (2017)

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Peng, Li, et al.
Publicado: (2016)

Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
por: XU, RONG-HE, et al.
Publicado: (2013)

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019)

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
por: Otsuki, Michio, et al.
Publicado: (2005)

Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study
por: Cai, De, et al.
Publicado: (2019)

Beraprost and Overall Survival in Cats with Chronic Kidney Disease
por: Ito, Hiroyuki, et al.
Publicado: (2023)

Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere
por: Luo, Yuling, et al.
Publicado: (2022)

Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
por: Coca, Vasile
Publicado: (2022)

Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
por: Coca, Dr. Vasile
Publicado: (2022)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016)

Sodium benzoate attenuates 2,8-dihydroxyadenine nephropathy by inhibiting monocyte/macrophage TNF-α expression
por: Oshima, Yoichi, et al.
Publicado: (2023)

Beraprost sodium attenuates the development of myocardial fibrosis after myocardial infarction by regulating GSK‐3β expression in rats
por: Li, Xing‐Xing, et al.
Publicado: (2023)

Alprostadil/papaverine/phentolamine: Delayed infected lymphocele: case report
Publicado: (2021)

Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension
por: Sun, Daoyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4ruvrk7u2ichq0slqt45djbom